Advisory Research’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-33,691
Closed -$862K 490
2023
Q3
$862K Sell
33,691
-38,895
-54% -$922K 0.12% 212
2023
Q2
$1.62M Sell
72,586
-116,650
-62% -$2.75M 0.21% 142
2023
Q1
$4.98M Buy
189,236
+12,131
+7% +$329K 0.82% 30
2022
Q4
$4.52M Sell
177,105
-8,913
-5% -$204K 0.43% 43
2022
Q3
$3.6M Buy
186,018
+73,033
+65% +$1.47M 0.35% 53
2022
Q2
$2.08M Buy
+112,985
New +$2.05M 0.2% 82
2019
Q2
Sell
-34,621
Closed -$1.16M 390
2019
Q1
$1.16M Buy
34,621
+8,587
+33% +$250K 0.02% 233
2018
Q4
$694K Buy
+26,034
New +$797K 0.01% 272

Other funds holding AVTA

Advisory Research's AVTA Position: Q4 2023 in Review

Advisory Research sold out of Avantax, Inc. Common Stock (AVTA) in Q4 2023, closing a stake of 33,691 shares — an estimated $862K sold.

Advisory Research first reported a position in AVTA in Q4 2018 and held it in 8 quarters. The position peaked at $4.98M in Q1 2023. 2 funds tracked by Wall St. Rank hold AVTA as of Q4 2023.

  • Advisory Research reported no remaining Avantax, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Advisory Research sold 33,691 Avantax, Inc. Common Stock shares in Q4 2023, an estimated $862K.
  • Advisory Research first reported a position in Avantax, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
  • Advisory Research's Avantax, Inc. Common Stock position peaked at $4.98M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q4 2023.

Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.